Trials
Search / Trial NCT06445218

Observational Study of Musculoskeletal Patients in an Emergency Department in France

Launched by HÔPITAL NOVO · May 31, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

Emergency Department Musculoskeletal Disorder

ClinConnect Summary

There is a crisis in the emergency department (ED) in France, as their number of consultations have constantly increased over the past ten years . Musculoskeletal disorders (MSK) are the most common cause of consultations in ED, as an example there is an average of 30% of ED consultations being for traumatic issues . Moreover, 90% of all patients coming in ED in France have a favourable prognosis of evolution (no risk of seriousness). In this situation, one of the propositions to help to reduce the ED burden is to allow a direct access to physiotherapists. They are the recommended professio...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria :
  • Patients aged between 18 and 68
  • Patients admitted to emergency with a triage by the Reception and Referral Nurse of 0, 1 or 2
  • * Patients who consulted for one of the following reasons:
  • Lower limb pain (T13.9) Lower limb trauma (M79.61) Upper limb pain (T11.9) Upper limb trauma (M79.60) Spinal pain (M54.9) Lumbar or flank pain (R10.3) Diffuse/unspecific pain (R52.9) Loss of sensitivity/paraesthesia
  • - Patients informed of the study and who did not object
  • Exclusion Criteria :
  • Patients with another reason for consultation associated with the first
  • Patients under guardianship / curatorship and patients under safeguard of justice.

Trial Officials

Benoit ANCEL

Principal Investigator

Hôpital NOVO

About Hôpital Novo

Hôpital Novo is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies and rigorous scientific methodologies. With a strong emphasis on collaboration and ethical practices, Hôpital Novo partners with healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Their commitment to patient safety, data integrity, and regulatory compliance ensures that all research initiatives are conducted to the highest standards, ultimately contributing to the development of new treatments and therapies that enhance healthcare delivery.

Locations

Pontoise, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0